Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Breast hyperplasia
ADR ID BADD_A00685
ADR Hierarchy
21      Reproductive system and breast disorders
21.05      Breast disorders
21.05.01      Benign and malignant breast neoplasms
21.05.01.007      Breast hyperplasia
Description A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma. [MeSH]
MedDRA Code 10006256
MeSH ID D002285
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Bilateral mammary hyperplasia | Breast hyperplasia | Hyperplasia breast | Mammary hyperplasia bilateral | Atypical breast hyperplasia | Atypical ductal hyperplasia | Atypical lobular hyperplasia | Pseudoangiomatous stromal hyperplasia | Carcinoma, Intraductal, Noninfiltrating | Carcinoma, Intraductal | Carcinomas, Intraductal | Intraductal Carcinoma | Intraductal Carcinomas | DCIS | Ductal Carcinoma In Situ | Intraductal Carcinoma, Noninfiltrating | Carcinoma, Noninfiltrating Intraductal | Carcinomas, Noninfiltrating Intraductal | Intraductal Carcinomas, Noninfiltrating | Noninfiltrating Intraductal Carcinoma | Noninfiltrating Intraductal Carcinomas | Atypical Ductal Hyperplasia | Atypical Ductal Hyperplasias | Ductal Hyperplasia, Atypical | Ductal Hyperplasias, Atypical | Hyperplasia, Atypical Ductal | Hyperplasias, Atypical Ductal
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000044%
BADD_D00551Cyclosporine0.000111%
BADD_D00809Escitalopram0.000038%
BADD_D00898Finasteride0.000099%
BADD_D01567Nilotinib0.000112%
BADD_D01709Penicillamine--
BADD_D01909Ramipril0.000093%
The 1th Page    1    Total 1 Pages
ADReCS-Target
ADR Term Drug Name Target